MTOR and cholangiocarcinoma: For induction of autophagy activity, we chose the mTOR pathway inhibitor Rapamycin because it is the major negative regulator of autophagy [51,52], mTOR pathway plays a central role in cell proliferation and growth, and inhibition of mTOR function can be a strategic approach in CC and HCC [13,53].